Renovaris Ltd.

About

Q&A

What is Renovaris Ltd.'s primary focus?

Renovaris Ltd. is a pre-clinical stage biopharmaceutical company focused on developing a novel, patent-pending topical therapeutic for Alopecia Areata (AA) and Androgenetic Alopecia (AGA).

What technology does Renovaris Ltd. utilize for its therapeutic delivery?

Renovaris Ltd. utilizes proprietary Nano-gel technology to deliver a synergistic combination of drugs directly to the hair follicle.

What is the intended application of Renovaris Ltd.'s therapeutic product?

Renovaris Ltd. aims for its therapeutic to be a first-line therapy for mild-to-moderate alopecia and a maintenance therapy for severe cases.

When was Renovaris Ltd. founded?

Renovaris Ltd. was founded in 2026.

Who are the co-founders of Renovaris Ltd.?

The co-founders of Renovaris Ltd. are Amos Ofer, who serves as CEO, and Prof. Taher Nassar, who serves as CSO.

Where is Renovaris Ltd. headquartered?

Renovaris Ltd. is headquartered in Nazareth, Israel.

What incubator supports Renovaris Ltd.?

Renovaris Ltd. is supported by the NGT Healthcare II Incubator.

Team · 2

Amos Ofer

Founder · CEO & Co-Founder

Prof. Taher Nassar

Founder · CSO & Co-Founder

Sectors & technology